The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1502
August 29, 2016
View Complete Issue         Table of Contents 2019 
An Oral Cholera Vaccine for Travelers (Vaxchora)
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
An Oral Cholera Vaccine for Travelers (Vaxchora)
August 29, 2016 (Issue: 1502)
The FDA has approved Vaxchora (PaxVax), a single-dose, oral, live-attenuated cholera vaccine, to protect against disease caused by Vibrio cholerae serogroup O1 in adults 18-64 years old traveling to cholera-affected areas. Vaxchora is the only...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: An Oral Cholera Vaccine for Travelers (Vaxchora)
Article code: 1502d
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.